JNJ-64457744

JNJ-64457744 · Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-64457744, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Single and Multiple Ascending Dose Study of JNJ-64457744 [Phase 1]